Company Profile

Pathways Bioscience LLC
Profile last edited on: 6/30/17      CAGE: 781R4      UEI: VGM4NLQQH7Y5

Business Identifier: Next-generation Nrf2 activating dietary supplement
Year Founded
2014
First Award
2017
Latest Award
2017
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

12635 East Montview Boulevard Suite 130
Aurora, CO 80045
   (720) 372-4815
   N/A
   www.pathwaysbio.com
Location: Single
Congr. District: 06
County: Adams

Public Profile

Pathways Bioscience develops and commercializes new products that act on cell signaling pathways that regulate the expression of cytoprotective genes for beneficial effects on health. A biomedical sciences company, Pathways Bioscience is focused on discovering and developing new agents, both small molecule drugs and dietary supplements, that influence gene expression pathways and exert beneficial effects, with particular emphasis on the Nuclear Factor, Erythroid 2 Like 2 (NFE2L2, or Nrf2) gene transcription factor, known as the master regulator of cell protection mechanisms. These activities are based on the concept that the best way to improve healthspan and overcome the health and wellness problems associated with aging is to support the body’s own defense mechanisms that allow it to protect and to heal itself

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Brooks Michael Hybertson

Company News

There are no news available.